This article was originally published in The Rose Sheet
FDA Raises Eyebrow At RapidLash Claims
You may also be interested in...
Revlon is closing facilities and reducing headcount to “drive operating efficiencies,” the firm says. More news in brief.
Stakeholders from industry, government and FDA discussed ideas for changing the agency’s oversight of cosmetics at a House subcommittee meeting March 27. The need for a national regulatory system, mandatory recalls, company and ingredient registration and adverse event reporting were debated.
After a disappointing 2010, things are looking up for Avon Products. For its fiscal 2011 first quarter, the firm booked revenue of $2.6 billion, up 7% over the same period last year, with a strong contribution from fragrance and color cosmetics, while profit tripled to reach $144 million.